在患有急性淋巴细胞白血病的老年患者中,使用基于儿科的协议-A前性研究改善了治疗结果
P Quist-Paulsen1, L Horvei2,3, J Dalgaard4
1Department of Hematology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
British journal of haematology
|September 14, 2025
概括
基于儿科的治疗方案对65岁以上的老年急性淋巴细胞白血病 (ALL) 患者有希望. 这种方法证明了有效性和耐受性,在挪威的一项研究中实现了50%的长期生存率.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 患有急性淋巴细胞白血病 (ALL) 的老年患者有史以来不良的预后.
- 对于年轻患者来说,ALL结局的改善并没有同样适用于老年人群.
- 需要针对老年ALL患者制定有效和耐受的治疗策略.
研究的目的:
- 评估新诊断ALL的老年患者 (≥65岁) 儿科治疗方案的可行性和有效性.
- 为了评估包括缓解率,生存率和复发率在内的结果,在这个特定的患者队列中.
主要方法:
- 在挪威进行的基于人口的前性研究.
- 患者接受了基于儿科的治疗方案:费城染色体 (Ph) 阴性ALL的基化阿斯巴拉金酶,Ph阳性ALL的伊马替尼.
- 对于脆弱的患者,允许降低剂量;根据Ph状态分层治疗.
主要成果:
- 招募了52名老年ALL患者 (平均年龄为70岁).
- 49名患者实现了缓解;两年和五年总生存率分别为60%和50%.
- 观察到的复发率很低,在36名没有死于其他原因的患者中,只有6例复发.
结论:
- 基于儿科的治疗方案在新诊断ALL的老年患者中耐受性很好,并且有效.
- 这种疗法取得了良好的结果,包括50%的长期存活率和低复发率.
- 这些发现支持使用适应的儿科方案来管理老年人的ALL.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.6K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.7K
相关概念视频
01:22Bone Marrow Sampling and Transplants
899
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
899
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212